approval
saveNALBUPHINE HYDROCHLORIDE — FDA approval
community read0 votes
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
same company · ±60 days · 5
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalNov 30, 2007
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalNov 30, 2007
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalNov 30, 2007
- approvalPROPOFOL: PROPOFOL — FDA approvalOct 30, 2007
- approvalPROPOFOL: PROPOFOL — FDA approvalJan 14, 2008
comments(0)
5-min edit window · permanent after that